$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-C]quinolin-4-amine 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/44
  • A61K-009/70
출원번호 US-0471440 (1995-05-31)
발명자 / 주소
  • Wick Steven M.
  • Schultz Helen Jensen
  • Nelson Gregory R.
  • Mitra Amit K.
  • Berge Stephen M.
출원인 / 주소
  • Riker Laboratories, Inc.
대리인 / 주소
    Griswold
인용정보 피인용 횟수 : 39  인용 특허 : 8

초록

Pharmaceutical formulations and adhesive-coated sheet materials for the topical and/or transdermal delivery of 1-isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine, including creams, ointments and pressure-sensitive adhesive compositions. Pharmacological methods of using the formulations and the adhesive-c

대표청구항

[ What is claimed is:] [1.] A substantially non-irritating pharmaceutical formulation for topical and/or transdermal administration of 1 -isobutyl- 1H-imidazo[4,5 -c]quinolin-4-amine, which formulation comprises:(a) a therapeutically effective amount of 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine;(

이 특허에 인용된 특허 (8)

  1. Gerster John F. (Woodbury MN), 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use.
  2. Mahjour Majid (Morris Plains NJ) Iyer Uma (Mendham NJ) Fawzi Mahdi B. (Flanders NJ), Penetration enhancement system.
  3. Patel Dinesh C. (Murray UT) Chang Yunik (Lakewood NJ), Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols.
  4. Eckert Theodor (Muenster DEX) Kemper Fritz H. (Muenster DEX) Wischniewski Martin (Neustadt a. Rbge. DEX) Hempel Reinhard (Hanover DEX), Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparati.
  5. Cheng Yu-Ling (Cupertino CA) Nedberge Diane E. (Los Altos CA) Sugihara Edna (Mountain View CA), Skin permeation enhancer compositions using glycerol monolaurate.
  6. Kigasawa Kazuo (Tokyo JPX) Ohtani Hideaki (Tokyo JPX) Tanaka Makoto (Tokyo JPX) Hayashida Shigeru (Tokyo JPX), Soft patch.
  7. Johnson Dee L. (Woodbury MN) Senta Therese A. (Minneapolis MN) Sirvio Larry M. (Cottage Grove MN), Topical medicament preparations.
  8. Wick Steven M. (Oakdale MN), Transdermal nitroglycerin delivery system.

이 특허를 인용한 특허 (39)

  1. Lindstrom, Kyle J.; Merrill, Bryon A.; Haraldson, Chad A.; Rice, Michael J.; Kshirsagar, Tushar A.; Heppner, Philip D.; Wurst, Joshua R.; Niwas, Shri; Johannessen, Sarah C., Alkoxy substituted imidazoquinolines.
  2. Krepski, Larry R.; Dellaria, Jr., Joseph F.; Duffy, Daniel E.; Amos, David T.; Zimmermann, Bernhard M.; Moser, William H., Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines.
  3. Ma, David Q.; Perman, Christopher S.; Skwierczynski, Raymond D.; Hedenstrom, John C., Aqueous gel formulations containing immune response modifiers.
  4. Perman, Christopher S.; Skwierczynski, Raymond D.; Ma, David Q.; Hedenstrom, John C., Aqueous gel formulations containing immune response modifiers.
  5. Niwas, Shri; Merrill, Bryon A.; Heppner, Philip D.; Kshirsagar, Tushar A.; Lundquist, Jr., Gregory D.; Amos, David T.; Lindstrom, Kyle J., Aryl substituted imidazonaphthyridines.
  6. Bonk, Jason D.; Dellaria, Jr., Joseph F., Arylalkenyl and arylalkynyl substituted imidazoquinolines.
  7. Lindstrom, Kyle J.; Martin, Hugues M. H.; Merrill, Bryon A.; Rice, Michael J.; Wurst, Joshua R.; Haraldson, Chad A.; Kshirsagar, Tushar A.; Heppner, Philip D.; Niwas, Shri; Griesgraber, George W.; Radmer, Matthew R., Aryloxy and arylalkyleneoxy substituted imidazoquinolines.
  8. Prince, Ryan B.; Rice, Michael J.; Wurst, Joshua R.; Merrill, Bryon A.; Kshirsagar, Tushar A.; Heppner, Philip D., Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines.
  9. Carson, Dennis A.; Cottam, Howard B.; Wrasidlo, Wolfgang; Wu, Christina C. N.; Daniels, Gregory A., Conjugates of synthetic TLR agonists and uses therefor.
  10. Carson, Dennis A.; Cottam, Howard B.; Wrasidlo, Wolfgang; Wu, Christina C. N.; Daniels, Gregory A., Conjugates of synthetic TLR agonists and uses therefor.
  11. Carson, Dennis A.; Wrasidlo, Wolfgang; Wu, Christina C. N., Conjugates of synthetic TLR agonists and uses therefor.
  12. Velez-Bernal, Ivan Dario; Robledo-Restrepo, Sara Maria; Robledo-Restrepo, Martha Beatriz; Ceballos-Maya, Alba Lucia; Giraldo-Alzate, Newar Andres; Gomez-Zuluaga, Alvaro; Zuluaga-Rivera, Juan Jose, Cream formulation with amphotericin B and oil in water useful for topical application to mucous tissue and skin against diseases produced by leishmaniasis.
  13. Abram, Albert Zorko; Goldstein, Iulian, Fatty acid pharmaceutical foam.
  14. Abram, Albert Zorko; Goldstein, Iulian, Fatty acid pharmaceutical foam.
  15. Yu, Chongxi, High penetration prodrug compositions of 1H-imidazo[4,5-C]quinolin-4-amines and 1H-imidazo[4,5-C]quinolin-4-amine-related compounds.
  16. Yu, Chongxi, High penetration prodrug compositions of 1H-imidazo[4,5-c]quinolin-4-amines and 1H-imidazo[4,5-c]quinolin-4-amine-related compounds and uses thereof.
  17. Kshirsagar, Tushar A.; Lundquist, Jr., Gregory D.; Amos, David T.; Dellaria, Jr., Joseph F.; Zimmermann, Bernhard M.; Heppner, Philip D., Hydroxylamine substituted imidazoquinolines.
  18. Bonk, Jason D.; Dellaria, Jr., Joseph F., Imidazoquinolinyl sulfonamides.
  19. Statham, Alexis S.; Nelson, Robert J., Immune response modifier formulations containing oleic acid and methods.
  20. Statham, Alexis S.; Nelson, Robert J., Immune response modifier formulations containing oleic acid and methods.
  21. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  22. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  23. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  24. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  25. Miller, Richard L.; Lee, James H.; Owens, Mary L., Methods of improving skin quality.
  26. Gregory, Jefferson J.; Nordsiek, Michael T., Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy.
  27. Gregory, Jefferson J.; Nordsiek, Michael T., Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy.
  28. Merrill, Bryon A.; Haraldson, Chad A.; Kshirsagar, Tushar A.; Niwas, Shri, Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines.
  29. Kshirsagar, Tushar A.; Lundquist, Jr., Gregory D.; Dellaria, Joseph F.; Radmer, Matthew R.; Zimmermann, Bernhard M., Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods.
  30. Kshirsagar, Tushar A.; Amos, David T.; Dellaria, Jr., Joseph F.; Heppner, Philip D.; Langer, Scott E.; Zimmermann, Bernhard M., Oxime substituted imidazo-containing compounds.
  31. Kshirsagar, Tushar A.; Lundquist, Gregory D.; Amos, David T.; Dellaria, Jr., Joseph F.; Zimmermann, Bernhard M.; Heppner, Philip D., Oxime substituted imidazoquinolines.
  32. Leoni, Lorenzo; Maj, Roberto; Pattarino, Franco; Vecchio, Carlo, Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration.
  33. Leoni, Lorenzo; Maj, Roberto; Pattarino, Franco; Vecchio, Carlo, Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration.
  34. Carson, Dennis A.; Cottam, Howard B.; Jin, Guangyi; Wu, Christina C. N.; Takabayashi, Kenji, Purine analogs.
  35. Hays, David S.; Danielson, Michael E.; Gerster, John F.; Niwas, Shri; Prince, Ryan B.; Kshirsagar, Tushar A.; Heppner, Philip D.; Moser, William H.; Moseman, Joan T.; Radmer, Matthew R.; Kavanagh, Maureen A.; Strong, Sarah A.; Bonk, Jason D., Pyrazolopyridines and analogs thereof.
  36. Griesgraber, George W.; Kshirsagar, Tushar A.; Slania, Sarah J.; Danielson, Michael E., Substituted chiral fused [1,2]imidazo[4,5-.
  37. Krepski, Larry R.; Dellaria, Jr., Joseph F.; Duffy, Daniel E.; Radmer, Matthew R.; Amos, David T., Substituted imidazo ring systems and methods.
  38. Carson, Dennis A.; Takabayashi, Kenji; Cottam, Howard B.; Chan, Michael; Wu, Christina C. N., TLR agonists.
  39. Carson, Dennis A.; Cottam, Howard B.; Hayashi, Tomoko; Chan, Michael, Toll-like receptor modulators and treatment of diseases.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로